Geniko Nosokomeio Thessalonikis “Papageorgiou” brings its patients and physicians quicker access to innovative medical treatments by joining Clinerion’s Patient Network Explorer platform.
Based in the city of Thessaloniki, Greece, “Papageorgiou” General Hospital has 746 beds and specializes in research on multiple sclerosis, dementia, pemphigus, plaque psoriasis, chronic kidney disease (anemia, diabetes mellitus type 2, bone metabolism in dialysis), ischemic heart disease and acute coronary syndromes, ventricular arrhythmias/dysfunction, prevention of sudden cardiac death, atrial fibrillation, heart failure, in various cancer areas (incl. breast cancer, non-small-cell lung cancer, urothelial/bladder cancer, gastric cancer, renal cell cancer, ovarian cancer, prostate cancer), bladder disorders (incl. neurogenic bladder disorder, overactive bladder disorder), urinary tract infections, erectile dysfunction, pathogenesis, vascular function and complications of cardiovascular risk factors and diseases such as essential hypertension, diabetes mellitus, hyperlipidemia, stroke etc. The hospital runs approximately 62 new clinical trials per year.
With the hospital joining Patient Network Explorer, patients at Geniko Nosokomeio Thessalonikis “Papageorgiou” will be matched to clinical trials being run by international pharmaceutical companies on innovative medical interventions, as well as those being run by the hospital’s own academic researchers. This gives patients and physicians at the hospital access to leading-edge treatment options and supports the acceleration of the introduction of these treatments into the market.
“With our experience, expertise and infrastructure, our hospital is in a strong position to support international trials,” says Vasileios Papas, Chairman of the Board of the hospital. “We are proud to have been recognized for infrastructure quality for implementation of clinical trials, fast-track administrative procedures, and a friendly organizational environment by the SFEE (the Hellenic Association of Pharmaceutical Companies).”
“Clinerion is thrilled to further expand our coverage of the Greek patient population through the Papageorgiou General Hospital,” says Ian Rentsch, CEO of Clinerion. “We already cover patients in Athens, and this will greatly benefit patients in the area of Thessaloniki, Greece’s second largest cosmopolitan area, in getting earlier access to medical innovations.”
About Clinerion
Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access.
Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.
Clinerion’s Patient Network Explorer: www.clinerion.com/index/OverviewOurSolutions/ClinerionPatientNetworkExplorer
Clinerion website: www.clinerion.com
About Geniko Nosokomeio Thessalonikis “Papageorgiou”
Papageorgiou General Hospital has been a pioneer in the Greek Public Health sector for many years. The commencement of its operation in August 1999 and the establishment of the Teaching Clinics in 2004, has completed in the best possible way the staffing of the Hospital (1.679 staff & approximately 500 students) which is currently engaged in a standing cooperation with the School of Medicine of the Aristotle University of Thessaloniki. The hospital includes: 30 clinics, 9 collaborative departments and 10 laboratory centers. The cornerstone of the hospital’s philosophy behind its operation is the provision of high quality & patient-centered healthcare services. Over 80.000 patients per year are being treated at the hospital on an impatient basis. Approximately 20.300 surgical operations and 325.000 exams are performed each year.
Geniko Nosokomeio Thessalonikis Papageorgiou website: www.papageorgiou-hospital.gr
